Product Datasheet
|
|
|
Product Description |
|
Product: |
Prekallikrein, Human Plasma |
Catalog Number: |
HPK |
Product Page: |
https://www.mol-innov.com/products/IHUPK1MG |
Description: |
Zymogen precursor of the plasma serine protease kallikrein. Human Prekallikrein is a single chain gamma globulin glycoprotein that participates in the early phase of contact activation, kinin formation and fibrinolysis. Prekallikrein purity is >95percent by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I & II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). |
Recommended Storage: |
SAMPLE |
Minimum Shelf Life: |
418.00 |
Source: |
5.0 mg/ml |
Molecular Weight: |
Proteins |
Extinction Coefficient: |
86,000 |
Antigen: |
-70 C |
Target: |
Frozen liquid |
Target Molecular Weight: |
KALLIKREIN/PREKALLIKREIN |
Host: |
1767 |
Clonality: |
5 |
Isotype: |
Human plasma |
Clone: |
s |
Applications: |
Dry ice |
Cross-reactivity: |
3 years from delivery |
|
Sample Characteristics |
|
Lot Number: |
HPK-IHUPK5MG |
Aliquot: |
1 x Human Prekallikrein Purified 5mg |
Concentration: |
440 |
Volume: |
1860 |
Titer: |
0.004M Sodium Acetate; 0.15M NaCl; pH 5.3 |
Buffer: |
SAMPLE |
Form: |
1.0 mg |
Preservative: |
0.04 ml |
|
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
|
For in vitro laboratory use only |
|
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |